Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa.
Journal Information
Full Title: BMC Neurol
Abbreviation: BMC Neurol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsJM, AB, WN, JL, WK, SS and GMB are employees of Janssen Pharmaceuticals. EH, CRM and SAM are employees of Mtech Access and received payment from Janssen Pharmaceuticals to carry out this review. NEG hhas received financial support from UCB, Argenx, Janssen, Merck, Roche, Alexion, Immunovant, Huma, Dianthus, Denka, and Grifols. Competing interests JM, AB, WN, JL, WK, SS and GMB are employees of Janssen Pharmaceuticals. EH, CRM and SAM are employees of Mtech Access and received payment from Janssen Pharmaceuticals to carry out this review. NEG hhas received financial support from UCB, Argenx, Janssen, Merck, Roche, Alexion, Immunovant, Huma, Dianthus, Denka, and Grifols."
"Funding Open access funding provided by University of Bergen. This study was funded by Janssen Pharmaceuticals."
"Trial registration The protocol for this systematic review was registered in PROSPERO: CRD42022328444."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025